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Caila D. Knighton(MS4)1, Sarah C. Corely (MS3)1, Hope E. Oddo
Moise, MD2
LSUHSC School of Medicine1, LSUHSC Department of Infectious Disease2

Introduction
Brucella is one of the most common zoonotic
infections in the world, typically spread from
infected farm animal to humans by ingestion of
unpasteurized food products or by contact with
infected tissue or fluids [1]. Endemic areas
include Mexico and other portions of central
South America. 500,000 cases are reported
yearly, however only about 100 to 200 are in
Northern America. Brucella is the pathogen
that causes the disease brucellosis (also known
as Undulant Fever, Malta Fever, and
Mediterranean Fever)[1]. Brucellosis presents
with insidious onset fever, night sweats, and
malaise. Physical findings tend to be variable
and highly nonspecific [2,5]. There are many
complications in the various organ systems
those with brucellosis can face with neurological
issues occurring in about 10 percent of cases,
these manifestations include meningitis,
encephalitis, and abscess and can occur during
any stage of infection [1,5]. In the setting of
neurobrucellosis, CSF findings include elevated
blood cells, elevated protein and low glucose, it
is very uncommon for the organism to be
recovered in the CSF [2].

Patient
presentation1
Patient presented to an outside hospital after being found
down in a sugarcane field. He was febrile to 104.7,
hypotensive, tachycardic to 160 with a GCS of 3. He had
an episode of emesis with new onset seizure activity and
agonal breathing and severe bilateral conjunctival
hemorrhages. He was refractory to IV fluid resuscitation,
started on pressors and intubated before being transferred
to UMC. Patient had a refractory metabolic acidosis with
pH of 7.23 with increasing creatinine up to 9.33. During his
ICU stay, he also had increasing ventilation requirements
being diagnosed with severe ARDS. Blood and CSF
cultures were drawn, while CSF did not grow bacteria,
blood cultures grew many colonies of Brucella. MRI head
and spine showed patchy enhancements throughout brain,
likely infectious, extensive microhemorrhages, and
enhancement of the cauda equina nerve roots suggestive of
arachnoiditis/encephalitis.

Patient History
The patient in this case study is a 36 y.o.
Mexican immigrant male with no prior medical
history, no home medications, no history of
surgery and a known anaphylactic reaction to
bee stings. From collateral it was obtained he
was here doing field work to send money back
home to his wife. Per patient’s father, he had
been staying in a moldy house with coworkers
and had eaten unpasteurized cheese. He
developed a mild illness that he did not seek
care for the week previously, as did some of the
coworkers. The morning of his initial
presentation, the patient felt fine and did not
mention any illness to his father.

Images 1-3: MRI Head showing patchy enhancements throughout brain.
Image 4: MRI Spine: showing enhancement in the cauda equina nerve
roots

Patient pressor requirement decreased after ten days, and
he was eventually extubated but continued to have
persistent tachycardia, fevers, oliguria, and emesis
refractory to all treatment. Patient with continued
improvement in mentation until two weeks after initial
presentation when he became hemodynamically unstable
and was stepped up to the ICU where he was once again
placed on pressors and intubated. It was discovered he had
an UGIB with unclear etiology and/or relation to brucella
infection. As of early October, repeat MRI brain and spine
is pending.
.

Lab Work
Initial lab work showed CSF with RBC count of 381, 2
WBC, protein of 178.7 and glucose of 168, gram stain
showed white blood cells but no organisms. Repeat
CSF studies showed WBC count increased to 11 with
decreased proteins and RBCs. Blood cultures originally
grew heavy brucella but have since cleared. He
continues to have leukocytosis intermittently in both
daily lab work and randomly drawn CSF samples.

Conclusions and Results
The optimal treatment for neurobrucellosis is
uncertain as data is very limited [3]. For adults, the
standard of care is 4 to 6 weeks of Ceftriaxone plus
Rifampin and Doxycycline for 4 to 6 months [3,4].
From studies, those patients who are treated with
ceftriaxone therapy are less likely to relapse and
represent with infection [3]. With this information, our
34 y.o. male was started on a prolonged course of IV
Ceftriaxone, Rifampin and Doxycycline with eventual
clearing of blood cultures. Currently, patient has not
returned to baseline and continues to face a tumulus
hospital course with multiple GI bleeds, ESBL UTIs,
and a continued encephalopathy from his bacterial
infection, however patient mentation is improving, he
is now able to speak in one-word phrases. He primarily
uses moans and groans to communicate but is slowly
regaining his physical strength and ability to both
follow commands and guide providers to what is
causing him discomfort or pain. He has a long course
ahead of him and after multiple months in the hospital,
he will be transferred to an LTAC for continued
support.
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